Clinical trial Recruiting at 1 site Interventional Ages 22 and up

Comparison of a new trifocal IOL with PanOptix Pro IOL in cataract surgery

Official title: Clinical Evaluation of a Novel Trifocal IOL

Run by Alcon Research · NCT07587138 · Data updated 2026-11-12

This study tests whether the investigational trifocal IOL LPYWT0 works as well as the PanOptix Pro trifocal IOL in people with cataracts undergoing cataract surgery in both eyes.

More Cataract trials

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment66 (estimated)
SponsorAlcon Research
Industry-sponsored
Locations5 sites (Sydney, New South Wales and 4 other locations)
StatusRecruiting
StartedOctober 9, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07587138 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing bilateral cataract surgery who meet specific refractive and ocular criteria, including appropriate IOL power between +15.0 and +25.0 D and low astigmatism (<1.00 D) in each eye, and the potential to achieve 0.2 logMAR or better with correction.

Probably not a fit

Patients with significant corneal disease, systemic or ocular conditions that could compromise results, or unsuitable IOL power/eye health may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with bilateral cataracts will have sequential cataract surgery, receiving the investigational LPYWT0 trifocal IOL in one eye and the commercially available PXYWT0 PanOptix Pro trifocal IOL in the other eye, about 7–14 days apart. The trial plans about 9 visits over roughly 7 months to compare visual outcomes between the two eyes. The study is conducted in India and the Philippines and aims to characterize the visual performance of the LPYWT0 IOL relative to a marketed trifocal lens.

Why it matters

Potential benefit: If successful, patients could gain access to a potentially new trifocal IOL option that may provide good vision at multiple distances.

How similar studies have gone: Previous studies with similar comparative approaches have shown mixed results; this study addresses a novel investigational IOL by direct comparison to an established trifocal lens.

Who can join: the full rules

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

* The calculated power needed for the artificial lens (IOL) must be between +15.0 and +25.0 D in each eye, designed to bring subject vision as close to "0.0" (neutral) as possible, meaning they will not be strongly nearsighted or farsighted after surgery.
* Subjects must have low levels of astigmatism (misshapen cornea) in the eyes (less than 1.00 D).
* In the doctor's opinion, the subjects have the potential to achieve good vision (0.2 logMAR, which is roughly 20/32 Snellen or better) in each eye after the surgery, when wearing the best possible spectacles or contact lenses.
* Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

* Clinically significant corneal diseases which may, according to the investigator's medical opinion, adversely affect visual outcomes.
* Any ocular or systemic health condition or medical issue that, in the investigator's medical opinion, could make the study results unreliable, prevent the person from finishing the study, or increase their safety risk.
* People who want to have one eye set for distance vision and the other for near vision.
* The doctor expects significant blurry vision (astigmatism) after the procedure.
* Other protocol-specified exclusion criteria may apply.

Where it's running

  • Asian Eye Institute
    Makati City, Philippines
    Recruiting
  • Personaleyes
    Sydney, New South Wales, Australia
    Not yet recruiting
  • Dr. Agarwal's Eye Hospital Limited
    Chennai, Tamil Nadu, India
    Not yet recruiting
  • Narayana Nethralaya
    Bangalore, India
    Not yet recruiting
  • Peregrine Eye Laser and Institute
    Makati City, Manila, Philippines
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.